Iranian Journal of Basic Medical Sciences

Iranian Journal of Basic Medical Sciences

Molecular mechanisms underlying the effects of regular exercise on substance use disorder-associated cognitive impairment and dementia risk: A narrative review

Document Type : Review Article

Authors
1 Department of Sports Behavioral and Cognitive Sciences, Sports and Health Sciences College, Tehran University, Tehran, Iran
2 Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
3 Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
10.22038/ijbms.2026.96470.20790
Abstract
Dementia is one of the most widespread neurodegenerative conditions worldwide and is accompanied by cell death in the central nervous system (CNS). Risk factors include age, genetics, CNS trauma, cardiovascular disease, environmental factors, and stressors. Stress, especially oxidative stress, disrupts mitochondrial respiration, causing mitochondrial damage in neurodegenerative illnesses like dementia. The role of oxidative stress in dementia progression has been studied recently. As a progressive disorder, addiction may be a stressor that induces oxidative stress. The psychological and psychophysiological effects of addiction can exacerbate oxidative stress, neuronal death, and dementia progression. Identifying an effective alternative therapy to prevent oxidative stress-induced dementia development could be advantageous. Exercise reverses dementia progression by lowering oxidative stress-related neuropathological alterations in addiction. Regular exercise can help overcome addiction’s cognitive effects in a complementary, affordable, and accessible way.
This review will discuss dementia progression and oxidative stress-induced dysfunction. We will also examine addiction as an oxidative stressor in this neurodegenerative illness. To this end, we searched PubMed and Google Scholar for articles published between 2015 and 2025 using the keywords dementia, cognitive impairment, exercise, physical activity, addiction, METH, and oxidative stress. Finally, the last part of the review provides information to improve the current understanding of the role of regular exercise in the progression of substance use disorder-associated cognitive impairment and dementia risk.
Keywords
Subjects

1. Radfar F, Shahbazi M, Tahmasebi Boroujeni S, Arab Ameri E, Farahmandfar M. Moderate aerobic training enhances the effectiveness of insulin therapy through hypothalamic IGF1 signaling in rat model of Alzheimer’s disease. Sci Rep 2024; 14:15996.
2. Zekry D, Epperson TK, Krause KH. A role for NOX NADPH oxidases in Alzheimer’s disease and other types of dementia? IUBMB Life 2003; 55:307-313. 
3. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013; 80:1778-1783. 
4. Parish AL. Degenerative or debilitative neurologic syndromes. Nurs Clin North Am 2018; 53:447-457.
5. Hafner M, Singler K. Definition and epidemiology of dementia: A review. Ther Umsch 2010; 67:57-61.
6. Radfar F, Shahbazi M, Tahmasebi Boroujeni S, Arabameri E, Farahmandfar M. Moderate exercise and insulin in combination protect against brain atrophy and weight loss by modulation of glucose metabolism in rat model of Alzheimer’s disease. Sport Sci Health Res 2024; 16:1-13. 
7. Farokhi Larijani S, Hassanzadeh G, Zahmatkesh M, Radfar F, Farahmandfar M. Intranasal insulin intake and exercise improve memory function in amyloid-β induced Alzheimer’s-like disease in rats: involvement of hippocampal BDNF-TrkB receptor. Behav Brain Res 2024; 460:114814. 
8. Bloom GS. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 2014; 71:505-508. 
9. Cummings JL, Benson DF. Subcortical dementia: review of an emerging concept. Arch Neurol 1984; 41:874-879. 
10. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol 2004; 3:19-28. 
11. Perneczky R, Tene O, Attems J, Giannakopoulos P, Ikram MA, Federico A, et al. Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group. BMC Med 2016; 14:162. 
12. Di Domenico F, Pupo G, Giraldo E, Badìa MC, Monllor P, Lloret A, et al. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients. Free Radic Biol Med. 2016; 91:1-9. 
13. Hsieh HL, Yang CM. Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int 2013; 2013:484613. 
14. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401:79-82. 
15. Li J, O W, Li W, Jiang ZG, Ghanbari HA. Oxidative stress and neurodegenerative disorders. Int J Mol Sci 2013; 14:24438-24475. 16. Powers SK, Deminice R, Ozdemir M, Yoshihara T, Bomkamp MP, Hyatt H. Exercise-induced oxidative stress: friend or foe? J Sport Health Sci 2020; 9:415-425. 
17. Carvalho C, Moreira PI. Oxidative stress: A major player in cerebrovascular alterations associated to neurodegenerative events. Front Physiol 2018; 9:806. 
18. Nock NL, Minnes S, Alberts JL. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders. Birth Defects Res 2017; 109:1711-1729. 
19. Powers SK, Criswell D, Lawler J, Ji LL, Martin D, Herb RA, et al. Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. Am J Physiol 1994;266: 375-380. 
20. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014; 94:909-950. 
21. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J 2012; 5:9-19.
22. Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid Redox Signal 2011; 14:593-605. 
23. Angelova PR, Horrocks MH, Klenerman D, Gandhi S, Abramov AY, Shchepinov MS. Lipid peroxidation is essential for α-synuclein-induced cell death. J Neurochem 2015; 133:582-589. 
24. Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 2019; 20:148-160. 
25. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443:787-795. 
26. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008; 57:178-201. 
27. Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010; 468:562-566. 
28. Popa-Wagner A, Mitran S, Sivanesan S, Chang E, Buga AM. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev 2013; 2013:963520. 
29. Choi DH, Hwang O, Lee KH, Lee J, Beal MF, Kim YS. DJ-1 cleavage by matrix metalloproteinase 3 mediates oxidative stress-induced dopaminergic cell death. Antioxid Redox Signal 2011; 14:2137-2150. 
30. Mao P. Oxidative stress and its clinical applications in dementia. J Neurodegener Dis 2013; 2013:319253. 
31. Markesbery WR, Carney JM. Oxidative alterations in Alzheimer’s disease. Brain Pathol 1999; 9:133-146. 
32. Grande G, Qiu C, Fratiglioni L. Prevention of dementia in an ageing world: evidence and biological rationale. Ageing Res Rev 2020; 64:101045. 
33. Galindo-Aldana GM. Drug abuse trends in Northwest Mexico: correlations between drug abuse and cognitive impairment. Rev Fac Med 2019; 67:673-680. 
34. Timcheh A, Ahmadimanesh M, Ghorbani H. Herbal medicines in Iran advertised as opioid withdrawal drugs: analysis by gas chromatography-mass spectrometry. Eur J Integr Med 2019; 25:55-59. 
35. Gardner EL. Addiction and brain reward and antireward pathways. In: Chronic Pain and Addiction. 2011. p. 22-60. 
36. Pierce RC, Kumaresan V. The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 2006; 30:215-238. 
37. Zeng XS, Geng WS, Wang ZQ, Jia JJ. Morphine addiction and oxidative stress: the potential effects of thioredoxin-1. Front Pharmacol 2020; 11:1-6.
38. Tzeng NS, Chien WC, Chung CH, Chang HA, Kao YC. Association between amphetamine-related disorders and dementia-a nationwide cohort study in Taiwan. Ann Clin Transl Neurol 2020; 7:1284-1295. 
39. Zhang K, Zhang Q, Jiang H, Du J, Zhou C, Yu S, et al. Impact of aerobic exercise on cognitive impairment and oxidative stress markers in methamphetamine-dependent patients. Psychiatry Res 2018; 266:328-333. 
40. Bahorik A, Bobrow K, Hoang T, Yaffe K. Increased risk of dementia in older female US veterans with alcohol use disorder. Addict 2021; 116:2049-2055. 
41. Kamal H, Tan GC, Ibrahim SF, Shaikh MF, Mohamed IN, Mohamed RMP, et al. Alcohol use disorder, neurodegeneration, Alzheimer’s and Parkinson’s disease: interplay between oxidative stress, neuroimmune response and excitotoxicity. Front Cell Neurosci 2020; 14:282. 
42. Hacimusalar Y, Karaaslan O, Bal C, Kocer D, Gok G. Methamphetamine’s effects on oxidative stress markers may continue after detoxification: a case-control study. Psychiatry Clin Psychopharmacol 2019; 29:1-8. 
43. Sajja RK, Rahman S, Cucullo L. Drugs of abuse and blood-brain barrier endothelial dysfunction: a focus on the role of oxidative stress. J Cereb Blood Flow Metab 2015; 35:172-178. 
44. Hulse GK, Lautenschlager NT, Tait RJ, Almeida OP. Dementia associated with alcohol and other drug use. Int Psychogeriatr 2005; 17:109-127. 
45. Calsolaro V, Edison P. Neuroinflammation in Alzheimer’s disease: current evidence and future directions. Alzheimers Dement 2016; 12:719-732. 
46. Jafari-Sabet M, Amiri S, Sheibani M, Fatahi N, Aghamiri H. Cross state-dependent memory retrieval between tramadol and ethanol: involvement of dorsal hippocampal GABAA receptors. Psychopharmacology (Berl) 2024; 241:139-152. 
47. Mohammadgholi A, Helia B, Rojin A, Majid R, Jafari-Sabet M, Motevalian M. Investigation of the protective effects of aripiprazole on methylphenidate-induced neurotoxicity in rats. Mol Neurobiol 2025; 62:11581-11595. 
48. Schiavone S, Jaquet V, Trabace L, Krause KH. Severe life stress and oxidative stress in the brain: from animal models to human pathology. Antioxid Redox Signal 2013; 18:1475-1490. 
49. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006; 16:3-63. 
50. Cassilhas RC, Tufik S, De Mello MT. Physical exercise, neuroplasticity, spatial learning and memory. Cell Mol Life Sci 2016; 73:975-983. 
51. Linke SE, Ussher M. Exercise-based treatments for substance use disorders: evidence, theory, and practicality. Am J Drug Alcohol Abuse 2015; 41:7-15. 
52. Lynch WJ, Peterson AB, Sanchez V, Abel J, Smith MA. Exercise as a novel treatment for drug addiction: A neurobiological and stage-dependent hypothesis. Neurosci Biobehav Rev 2013; 37:1622-1644. 
53. Thirupathi A, Pinho RA. Effects of reactive oxygen species and interplay of antioxidants during physical exercise in skeletal muscles. J Physiol Biochem 2018; 74:359-367. 
54. Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 2008; 88:1243-1276. 
55. Somani SM, Ravi R, Rybak LP. Effect of exercise training on antioxidant system in brain regions of rat. Pharmacol Biochem Behav 1995; 50:635-639. 
56. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006; 127:397-408. 
57. Perluigi M, Di Domenico F, Barone E, Butterfield DA. mTOR in Alzheimer disease and its earlier stages: links to oxidative damage in the progression of this dementing disorder. Free Radic Biol Med 2021; 169:382-396. 
58. Wang L, Wang X, Wang Q. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Biomed Res 2017; 28:3568-3573. 
59. Vargas-Mendoza N, Morales-González Á, Madrigal-Santillán EO, Madrigal-Bujaidar E, Álvarez-González I, García-Melo LF, et al. Anti-oxidant and adaptative response mediated by Nrf2 during physical exercise. Antioxidants (Basel) 2019; 8:196. 
60. Teixeira AM, Reckziegel P, Müller L, Pereira RP, Roos DH, Rocha JBT, et al. Intense exercise potentiates oxidative stress in striatum of reserpine-treated animals. Pharmacol Biochem Behav 2009; 92:231-235. 
61. Mobasheri A, Avila J, Cózar-Castellano I, Brownleader MD, Trevan M, Francis MJO, et al. Na+, K+-ATPase isozyme diversity: Comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 2000; 20:51-91. 
62. Teixeira A, Müller LG, Reckziegel P, Boufleur N, Pase CS, Villarinho JG, et al. Beneficial effects of an innovative exercise model on motor and oxidative disorders induced by haloperidol in rats. Neuropharmacology 2011; 60:432-438. 
63. Esposito F, Ammendola R, Faraonio R, Russo T, Cimino F. Redox control of signal transduction, gene expression and cellular senescence. Neurochem Res 2004; 29:617-628. 
64. Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004; 3:205-214. 
65. Segat HJ, Kronbauer M, Roversi K, Schuster AJ, Vey LT, Roversi K, et al. Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats. Behav Brain Res 2014; 262:94-100. 
66. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DEH, Truong HT, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005; 48:303-314. 
67. Biedermann S, Fuss J, Zheng L, Sartorius A, Falfán-Melgoza C, Demirakca T, et al. In vivo voxel based morphometry: detection of increased hippocampal volume and decreased glutamate levels in exercising mice. Neuroimage 2012; 61:1206-1212. 
68. Real CC, Ferreira AFB, Hernandes MS, Britto LRG, Pires RS. Exercise-induced plasticity of AMPA-type glutamate receptor subunits in the rat brain. Brain Res 2010; 1363:63-71. 
69. Liste I, Guerra MJ, Caruncho HJ, Labandeira-Garcia JL. Treadmill running induces striatal Fo’s expression via NMDA glutamate and dopamine receptors. Exp Brain Res 1997; 115:458-469.
70. Hatzigiakoumis DS, Martinotti G, Di Giannantonio M, Janiri L. Anhedonia and substance dependence: Clinical correlates and treatment options. Front Psychiatry 2011; 2:10. 
71. O’Dell SJ, Galvez BA, Ball AJ, Marshall JF. Running wheel exercise ameliorates methamphetamine-induced damage to dopamine and serotonin terminals. Synapse 2012; 66:71-80. 
72. Mandyam CD, Wee S, Eisch AJ, Richardson HN, Koob GF. Methamphetamine self-administration and voluntary exercise have opposing effects on medial prefrontal cortex gliogenesis. J Neurosci 2007; 27:11442-11450. 
73. Ganzer F, Bröning S, Kraft S, Sack PM, Thomasius R. Weighing the evidence: A systematic review on long-term neurocognitive effects of cannabis use in abstinent adolescents and adults. Neuropsychol Rev 2016; 26:186-222. 
74. Greenwood BN, Foley TE, Le TV, Strong PV, Loughridge AB, Day HEW, et al. Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway. Behav Brain Res 2011; 217:354-362. 
75. Gomez-Pinilla F, Zhuang Y, Feng J, Ying Z, Fan G. Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation. Eur J Neurosci 2011; 33:383-390.
76. Dillard CJ, Litov RE, Savin WM, Dumelin EE, Tappel AL. Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation. J Appl Physiol 1987; 62:927-932.
77. Powers SK, Radak Z, Ji LL. Exercise-induced oxidative stress: past, present and future. J Physiol 2016; 594:5081-5092.
78. Hoffman JR, Im J, Kang J, Maresh CM, Kraemer WJ, French D, et al. Comparison of low- and high-intensity resistance exercise on lipid peroxidation: role of muscle oxygenation. J Strength Cond Res 2007; 21:118-122. 
79. Gomes MJ, Pagan LU, Lima ARR, Reyes DRA, Martinez PF, Damatto FC, et al. Effects of aerobic and resistance exercise on cardiac remodelling and skeletal muscle oxidative stress of infarcted rats. J Cell Mol Med 2020; 24:5352-5362. 
80. González-Bartholin R, Mackay K, Valladares-Ide D, Zbinden-Foncea H, Nosaka K, Peñailillo L. Changes in oxidative stress, inflammation and muscle damage markers following eccentric versus concentric cycling in older adults. Eur J Appl Physiol 2019; 119:2301-2312. 
81. Bloomer RJ, Fry AC, Falvo MJ, Moore CA. Protein carbonyls are acutely elevated following single set anaerobic exercise in resistance trained men. J Sci Med Sport 2007; 10:411-417.
82. Cantón-Suárez A, Sánchez-Valdeón L, Bello-Corral L, Cuevas MJ, Estébanez B. Understanding the molecular impact of physical exercise on Alzheimer’s disease. Int J Mol Sci 2024; 25:13576. 
83. Li H, Su W, Cai J, Zhao L, Li Y. Effects of exercise of different intensities on withdrawal symptoms among people with substance use disorder: a systematic review and meta-analysis. Front Physiol 2023; 14:1126777. 
84. Verdejo-Garcia A, Garcia-Fernandez G, Dom G. Cognition and addiction. Dialogues Clin Neurosci 2019; 21:281-290. 
85. Zhai X, Jin J, Zhu T, Cabral DAR, Wang D, Chen J, et al. Effects of acute aerobic exercise on emotional memory formation in individuals with methamphetamine use disorder: encoding vs consolidation. Psychol Sport Exerc 2025; 79:102842.
86. Turan Ç, Güliz Ş, Ne S, Budak Y, Erel Ö, Ömer Ş. Oxidative stress and inflammatory biomarkers in people with methamphetamine use disorder. Clin Psychopharmacol Neurosci 2023; 21:572-582.
87. Afzali S. Salivary biomarkers of oxidative stress in methamphetamine users: a case-control study. Nov Clin Med 2022; 1:95-100.
88. Wang Y, Luo D, Jiang H, Song Y, Wang Z, Shao L, et al. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials. Open Life Sci 2023; 18:20220668. 

Articles in Press, Accepted Manuscript
Available Online from 10 November 2026